LYRA
Price
$0.17
Change
-$0.01 (-5.56%)
Updated
Dec 18, 04:59 PM (EDT)
77 days until earnings call
ROQAF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
Ad is loading...

LYRA vs ROQAF

Header iconLYRA vs ROQAF Comparison
Open Charts LYRA vs ROQAFBanner chart's image
Lyra Therapeutics
Price$0.17
Change-$0.01 (-5.56%)
Volume$885
CapitalizationN/A
Roquefort Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$600
CapitalizationN/A
LYRA vs ROQAF Comparison Chart
Loading...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYRA vs. ROQAF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRA is a Hold and ROQAF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (LYRA: $0.18 vs. ROQAF: $0.05)
Brand notoriety: LYRA and ROQAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYRA: 109% vs. ROQAF: 100%
Market capitalization -- LYRA: $11.91M vs. ROQAF: $7.75M
LYRA [@Biotechnology] is valued at $11.91M. ROQAF’s [@Biotechnology] market capitalization is $7.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYRA’s FA Score shows that 1 FA rating(s) are green whileROQAF’s FA Score has 1 green FA rating(s).

  • LYRA’s FA Score: 1 green, 4 red.
  • ROQAF’s FA Score: 1 green, 4 red.
According to our system of comparison, LYRA is a better buy in the long-term than ROQAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYRA’s TA Score shows that 3 TA indicator(s) are bullish.

  • LYRA’s TA Score: 3 bullish, 5 bearish.

Price Growth

LYRA (@Biotechnology) experienced а -13.74% price change this week, while ROQAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

LYRA is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LYRA($11.9M) has a higher market cap than ROQAF($7.75M). ROQAF YTD gains are higher at: -58.333 vs. LYRA (-96.527).
LYRAROQAFLYRA / ROQAF
Capitalization11.9M7.75M154%
EBITDAN/AN/A-
Gain YTD-96.527-58.333165%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
LYRA
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-1.94%
ROQAF - LYRA
85%
Closely correlated
N/A
GLYC - LYRA
75%
Closely correlated
-2.83%
EYPT - LYRA
59%
Loosely correlated
+5.39%
HSTC - LYRA
29%
Poorly correlated
N/A
BCYC - LYRA
27%
Poorly correlated
+0.13%
More

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been closely correlated with LYRA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if ROQAF jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
LYRA - ROQAF
85%
Closely correlated
-1.94%
GLYC - ROQAF
72%
Closely correlated
-2.83%
EYPT - ROQAF
37%
Loosely correlated
+5.39%
RIGL - ROQAF
22%
Poorly correlated
-3.61%
RYTM - ROQAF
21%
Poorly correlated
+2.81%
More